Jaguar Health (JAGX) Operating Leases (2019 - 2026)
Jaguar Health's (JAGX) quarterly Operating Leases came in at $898000.0 in Q1 2026, down 10.02% year-on-year from $998000.0 in Q1 2025, and up 0.67% on a QoQ basis from $892000.0 in Q4 2025.
Jaguar Health (JAGX) Operating Leases (2019 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 7 years of Operating Leases data on file, last reported at $898000.0 in Q1 2026.
- On a quarterly basis, Operating Leases fell 10.02% year-over-year to $898000.0 in Q1 2026; TTM through Mar 2026 was $898000.0, a 10.02% decrease from a year earlier, with the FY2025 full-year figure at $892000.0, up 30.03% from the prior year.
- Operating Leases for Q1 2026 stood at $898000.0, up from $892000.0 in the prior quarter.
- Over the last five years, Operating Leases for JAGX reached as high as $998000.0 in Q1 2025 and fell as low as $351000.0 in Q3 2023.
- Historically, Operating Leases has averaged $788352.9 across 5 years, with a median of $868000.0 in 2022.
- Across the five-year window, Operating Leases sank 52.44% in 2023 and jumped 114.81% in 2024, its largest moves.
- Year by year, Operating Leases stood at $725000.0 in 2022, then climbed by 22.21% to $886000.0 in 2023, then dropped by 22.57% to $686000.0 in 2024, then surged by 30.03% to $892000.0 in 2025, then gained by 0.67% to $898000.0 in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $898000.0 in Q1 2026, $892000.0 in Q4 2025, and $918000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 898,000.00 |
| Dec 31, 2025 | 892,000.00 |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | 960,000.00 |
| Mar 31, 2025 | 998,000.00 |
| Dec 31, 2024 | 686,000.00 |
| Sep 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 873,000.00 |
| Dec 31, 2023 | 886,000.00 |
| Sep 30, 2023 | 351,000.00 |
| Jun 30, 2023 | 495,000.00 |
| Mar 31, 2023 | 627,000.00 |
| Dec 31, 2022 | 725,000.00 |
| Sep 30, 2022 | 738,000.00 |
| Jun 30, 2022 | 868,000.00 |
| Mar 31, 2022 | 921,000.00 |
| Dec 31, 2021 | 919,000.00 |
| Sep 30, 2021 | 826,000.00 |
| Jun 30, 2021 | 907,000.00 |